FDA Clears IND Application and Grants Orphan Drug Designation to an Experimental Therapy for Progressive Multifocal Leukoencephalopathy
According to a story from PR Newswire, the cell therapy company Cellevolve Bio, Inc., recently announced that the US Food and Drug Administration (FDA) has advanced the development of its…